| __timestamp | Bristol-Myers Squibb Company | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 241751000 |
| Thursday, January 1, 2015 | 5920000000 | 322292000 |
| Friday, January 1, 2016 | 4940000000 | 344320000 |
| Sunday, January 1, 2017 | 6411000000 | 374644000 |
| Monday, January 1, 2018 | 6345000000 | 414604000 |
| Tuesday, January 1, 2019 | 6148000000 | 466000000 |
| Wednesday, January 1, 2020 | 11143000000 | 535000000 |
| Friday, January 1, 2021 | 10195000000 | 643000000 |
| Saturday, January 1, 2022 | 9509000000 | 833000000 |
| Sunday, January 1, 2023 | 9299000000 | 899625000 |
| Monday, January 1, 2024 | 11159000000 | 901530000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key. Bristol-Myers Squibb Company and Ionis Pharmaceuticals, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Bristol-Myers Squibb consistently outpaced Ionis, with R&D expenses peaking at over $11 billion in 2020, a staggering 1,200% more than Ionis's highest expenditure in the same period.
While Ionis Pharmaceuticals has shown a steady increase in R&D spending, reaching nearly $900 million in 2023, it remains a fraction of Bristol-Myers Squibb's investment. This disparity highlights the different scales at which these companies operate, with Bristol-Myers Squibb leveraging its resources to maintain a competitive edge in innovation. As the pharmaceutical landscape evolves, these investments will likely play a crucial role in shaping future breakthroughs.
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Comparing Innovation Spending: Bristol-Myers Squibb Company and Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
R&D Insights: How Ionis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated